The analog insulin Walmart developed with Novo Nordisk will cost about $73 per vial or $86 for a package of prefilled insulin pens. Eli Lilly’s generic version of insulin costs $137.35 per vial, according to CNBC.
Mr. Ricks told CNBC he welcomes the competition from Walmart and that Eli Lilly will look at “further options” to reduce insulin prices.
“If we can reach one more patient with more affordable insulin, we’re going to try to do that,” he said.
He also pointed to two efforts from Eli Lilly to lower costs for people with diabetes, such as launching a half-price generic version of its insulin called insulin lispro in 2019, as well as capping out-of-pocket costs for insulin at $35 per month, CNBC reported.
Eli Lilly has faced criticism from politicians in both parties over its insulin prices.
Read the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
